Injection Site Reactions: You may experience redness, itching, or swelling at the injection site
Historically, no, but qualifying Medicare beneficiaries can get coverage for Wegovy from July 1, 2026, until December 31, 2027, via the new Medicare GLP-1 Bridge program
Once approved, your medication is delivered directly to your doorstep, along with continuous provider support
a contaminated injectable is more concerning because it bypasses several normal barriers
Results showed that tirzepatide reduced the odds for all observed cardiometabolic abnormalities, including a 34% reduction in odds for decreased HDL-C, 72% reduction for MetS
Maximizing Results With Weight Loss Injections Whether you choose semaglutide or tirzepatide, the injection alone wont do all the work